Ckip-1 3'UTR通过激活CaMKK2/AMPK/cTNI通路来缓解长时间睡眠剥夺引起的心脏功能障碍
Beilei Dong1,2,3, Rui Xue4, Jianwei Li2
1Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Molecular biomedicine
|June 13, 2024
概括
长时间的睡眠剥夺 (SD) 损害了小鼠的心脏功能和结构. 恢复氨酸激酶-2 - 交互蛋白-1 3'未翻译区域 (CKIP-1 3'UTR) 保护免受SD诱导的心脏病.
科学领域:
- 心血管生物学 心血管生物学
- 睡眠医学 睡眠医学
- 分子心脏病学分子心脏病学
背景情况:
- 睡眠不足 (SD) 对心血管健康构成重大威胁,但其潜在机制仍然不太了解.
- 目前对SD引起的心脏病的治疗策略有限,这凸显了对新型药物点的需求.
研究的目的:
- 在小鼠模型中研究长期SD对心脏结构和功能的影响.
- 阐明SD诱导的心脏损伤背后的分子机制,重点关注素激酶-2 - 相互作用蛋白-1 (CKIP-1) 的作用.
主要方法:
- 使用心声学,RT-q-PCR,马森染色,ELISA,转录测序和西式涂抹来评估心脏功能和分子变化.
- 小鼠接受了五周的SD,以诱导心脏重塑和损伤.
- 使用腺病毒介导的CKIP-1 3'未翻译区域 (3'UTR) 的过度表达来评估其治疗潜力.
主要成果:
- SD显著损害心脏功能,增加心脏重塑标记 (ANP) 和诱导纤维化.
- 心脏损伤的生物标志物 (CK,CK-MB,ANP,BNP,cTn-T) 在SD后升高.
- SD改变了信号传递和心脏收缩通路中的基因,抑制了CaMKK2 / AMPK / cTNI通路,同时降低了CKIP-1 3'UTR水平.
结论:
- 长时间的SD导致心脏功能障碍和心脏通过涉及CaMKK2 / AMPK / cTNI通路的机制重塑.
- CKIP-1 3'UTR在调节心脏对SD的反应方面发挥着至关重要的作用.
- 对CKIP-1 3'UTR的过度表达显示了通过重新激活CaMKK2/AMPK/cTNI通路来治疗睡眠剥夺引起的心脏病的治疗前景.
相关概念视频
Insufficient Sleep and Sleep Deprivation
139
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
139
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


